First US patient enrolled in device study to reduce coronary microvascular dysfunction

The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.

Jun 19, 2026 - 23:00
 0  1
First US patient enrolled in device study to reduce coronary microvascular dysfunction
The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow